Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.

ABSTRACT:

SUBMITTER: Beaver JA 

PROVIDER: S-EPMC5806609 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature